Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

235
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
235
Survival Curves01:18

Survival Curves

151
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
151
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

137
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
137
Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

207
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
207

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reduction techniques for survival analysis.

Lifetime data analysis·2026
Same author

Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential.

Communications medicine·2026
Same author

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

bioRxiv : the preprint server for biology·2026
Same author

Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.

HemaSphere·2026
Same author

Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data.

BioData mining·2026
Same author

A novel diagnostic serum protein signature for pediatric inflammatory bowel disease.

Journal of pediatric gastroenterology and nutrition·2026
Same journal

MCFST: Spatial domain identification method based on multi-view graph convolutional network and graph fusion network.

Bioinformatics (Oxford, England)·2026
Same journal

SpaBiT: Enhancing Spatial Transcriptomics Resolution via Bidirectional Attention Transformers.

Bioinformatics (Oxford, England)·2026
Same journal

EDEL: Enhancing Dense Retrievers for Curation of Biomedical Knowledge Bases.

Bioinformatics (Oxford, England)·2026
Same journal

Informative Relational Learning for Adverse Reaction Prediction with Enhanced Generalization to Novel Drugs.

Bioinformatics (Oxford, England)·2026
Same journal

An interpretable deep learning framework uncovers features governing CRISPR-Cas9 genome-editing efficiency.

Bioinformatics (Oxford, England)·2026
Same journal

3DICE: Interpretable 3D Cross-Modal Learning for Drug-Target Interaction Prediction and Large-Scale Drug Discovery.

Bioinformatics (Oxford, England)·2026
查看所有相关文章

相关实验视频

Updated: Jul 1, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

关于生存建模的教程与omics数据的应用.

Zhi Zhao1,2, John Zobolas1,2, Manuela Zucknick1,3

  • 1Oslo Centre for Biostatistics and Epidemiology (OCBE), Department of Biostatistics, Faculty of Medicine, University of Oslo, Oslo 0372, Norway.

Bioinformatics (Oxford, England)
|March 6, 2024
PubMed
概括
此摘要是机器生成的。

本研究介绍了一种工作流程,用于分析高维的奥米克数据,以确定患者生存标志物. 它使用Cox类型的惩罚回归和贝叶斯模型来选择特征,帮助个性化医学.

更多相关视频

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.5K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

相关实验视频

Last Updated: Jul 1, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.5K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

科学领域:

  • 生物医学信息学 生物医学信息学
  • 基因组学就是基因组学.
  • 统计遗传学 统计遗传学

背景情况:

  • 个性化医疗依赖于确定患者生存的预后标志物.
  • 奥米克技术产生了大量的数据集 (基因组学,转录组学,蛋白质组学等). 对于生存预后.
  • 高维的奥米克数据在分析患者存活率的分子关联方面存在挑战.

研究的目的:

  • 介绍适用于高维奥米克数据的生存分析的一般工作流程.
  • 为了促进与生存相关的特征的识别和生存模型的验证.
  • 为了应对在生存预后中大规模,相关的奥米克数据集所带来的挑战.

主要方法:

  • 专注于特征选择的考克斯类惩罚回归.
  • 纳入生存分析的等级贝叶斯模型.
  • 工作流适用于高维的奥米克数据,包括基因组学和转录组学.

主要成果:

  • 已经开发了一种用于对高维的奥米克数据进行生存分析的通用工作流.
  • 工作流允许识别与生存相关的特征.
  • 该框架支持对患者结果的生存模型的验证.

结论:

  • 提出的工作流提供了一个可靠的方法,使用omics数据进行生存分析.
  • 这种方法可以加强个性化疾病预防和治疗策略的开发.
  • 一个R教程可用于实际实施和评估生存模型.